FY2024 Labor HHS Education Appropriations bill;
FY2024 Defense Appropriations bill;
Pandemic All Hazards Preparedness Act Reauthorization;
FY2024 Further Consolidated Appropriations Act (H.R. 2882)
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Duration: June 8, 2021
to
present
General Issues: Budget/Appropriations , Health Issues , Manufacturing
Spending: about $2,430,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Defense - Dept of (DOD), Office of Management & Budget (OMB), Natl Economic Council (NEC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Valerie Jewett Associate Staff, Rep. Frelinghuysen
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, PHLOW CORPORATION had in-house lobbyists. The report was filed on April 22.
Original Filing: 301574604.xml
Lobbying Issues
FY2024 Labor HHS Education Appropriations bill;
FY2024 Defense Appropriations bill;
Pandemic All Hazards Preparedness Act Reauthorization;
FY2024 Further Consolidated Appropriations Act (H.R. 2882)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Agencies Lobbied
Health & Human Services - Dept of (HHS)
4th Quarter, 2023
In Q4, PHLOW CORPORATION had in-house lobbyists. The report was filed on Jan. 21.
Original Filing: 301534581.xml
Lobbying Issues
FY2024 Labor HHS Education Appropriations bill;
FY2024 Defense Appropriations bill;
FY2024 NDAA;
Pandemic All Hazards Preparedness Act Reauthorization
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Agencies Lobbied
Health & Human Services - Dept of (HHS)
3rd Quarter, 2023
In Q3, PHLOW CORPORATION had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301512918.xml
Lobbying Issues
FY2024 Labor HHS Education Appropriations bill;
FY2024 Defense Appropriations bill;
FY2024 NDAA;
Pandemic All Hazards Preparedness Act Reauthorization
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Agencies Lobbied
Health & Human Services - Dept of (HHS)
2nd Quarter, 2023
In Q2, PHLOW CORPORATION had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301489965.xml
Lobbying Issues
FY2024 Labor HHS Education Appropriations bill;
FY2024 Defense Appropriations bill;
FY2024 NDAA;
Pandemic All Hazards Preparedness Act Reauthorization
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity;
DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Agencies Lobbied
Health & Human Services - Dept of (HHS)
1st Quarter, 2023
In Q1, PHLOW CORPORATION had in-house lobbyists. The report was filed on April 20, 2023.
Original Filing: 301462773.xml
Lobbying Issues
Appropriations for the Departments of Labor and Health and Human Services
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Type of Issue
Health Issues
4th Quarter, 2022
In Q4, PHLOW CORPORATION had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301441230.xml
Lobbying Issues
Agriculture Appropriations, H.R. 4356 and S. 2599 (FDA regulatory oversight of essential medicines catalogue);
H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023;
H.R.2617 - Consolidated Appropriations Act, 2023
Agencies Lobbied
U.S. Senate
Lobbying Issues
PREPARE Act H.R. 5388 and S. 2740 (no specific provisions);
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
Health & Human Services - Dept of (HHS)
3rd Quarter, 2022
In Q3, PHLOW CORPORATION had in-house lobbyists. The report was filed on Oct. 21, 2022.
Original Filing: 301420387.xml
Lobbying Issues
Agriculture Appropriations, H.R. 4356 and S. 2599 (FDA regulatory oversight of essential medicines catalogue)
H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Agencies Lobbied
U.S. Senate
Lobbying Issues
PREPARE Act H.R. 5388 and S. 2740 (no specific provisions);
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
Health & Human Services - Dept of (HHS)
2nd Quarter, 2022
In Q2, PHLOW CORPORATION had in-house lobbyists. The report was filed on July 19, 2022.
Original Filing: 301388132.xml
Lobbying Issues
Agriculture Appropriations, H.R. 4356 and S. 2599 (FDA regulatory oversight of essential medicines catalogue)
H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Agencies Lobbied
U.S. Senate
Lobbying Issues
PREPARE Act H.R. 5388 and S. 2740 (no specific provisions);
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
Health & Human Services - Dept of (HHS)
1st Quarter, 2022
In Q1, PHLOW CORPORATION had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301372060.xml
Lobbying Issues
Labor-HHS-Education Appropriations, H.R. 4502 and S. 3062 (ASPR, pharmaceutical supply chain, funding for pandemic preparedness infrastructure);
Agriculture Appropriations, H.R. 4356 and S. 2599 (FDA regulatory oversight of essential medicines catalogue)
Agencies Lobbied
U.S. Senate
Lobbying Issues
PREPARE Act H.R. 5388 and S. 2740 (no specific provisions);
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
Health & Human Services - Dept of (HHS)
4th Quarter, 2021
In Q4, PHLOW CORPORATION had in-house lobbyists. The report was filed on Jan. 21, 2022.
Original Filing: 301339241.xml
Lobbying Issues
Labor-HHS-Education Appropriations, H.R. 4502 and S. 3062 (ASPR, pharmaceutical supply chain, funding for pandemic preparedness infrastructure);
Agriculture Appropriations, H.R. 4356 and S. 2599 (FDA regulatory oversight of essential medicines catalogue)
Agencies Lobbied
U.S. Senate
Lobbying Issues
PREPARE Act H.R. 5388 and S. 2740 (no specific provisions);
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrations activities related to pharmaceutical supply chain and domestic capacity
Agencies Lobbied
Health & Human Services - Dept of (HHS)
3rd Quarter, 2021
In Q3, PHLOW CORPORATION had in-house lobbyists. The report was filed on Oct. 20, 2021.
Original Filing: 301313862.xml
Lobbying Issues
FY 22 Labor HHS Appropriations, Agriculture Appropriations bills
Agencies Lobbied
U.S. Senate
Lobbying Issues
PREPARE Act H.R. 5388 and S. 2740 (no specific provisions)
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
PHLOW CORPORATION filed a lobbying registration on July 30, 2021 for in-house lobbying efforts, effective June 8, 2021.
Original Filing: 301293309.xml
Issue(s) they said they’d lobby about: FY 22 appropriations bills for the Department of Agriculture and the Department of Health and Human Services; Issues related to FDA oversight and supply chain security .
2nd Quarter, 2021
In Q2, PHLOW CORPORATION had in-house lobbyists. The report was filed on July 30, 2021.
Original Filing: 301293336.xml
Lobbying Issues
FY 22 appropriations bills for the Department of Agriculture and the Department of Health and Human Services
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FDA oversight and supply chain security
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
PHLOW CORPORATION filed a lobbying registration on July 29, 2021 for in-house lobbying efforts, effective June 8, 2021.
Original Filing: 301293203.xml
Issue(s) they said they’d lobby about: FY 22 appropriations bills for the Department of Agriculture and the Department of Health and Human Services;
Issues related to FDA oversight and supply chain security .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...